Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estrogen in Breast Cancer Patients on Letrozole
NCT06654570Phase 2Completed
- Sponsor
- Helsinki University Hospital
- Start
- Apr 2020
- Primary completion
- Oct 2024
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol in Vulvovaginal atrophy (VVA), sponsored by Helsinki University Hospital. Started Apr 2020; status: completed.
02
Drugs
estradiol
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT06654570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06654570.